Gabapentin
Product Images NDC 63304-629

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63304-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Contain100 (Contain100)

This is a medication called Gabapentin, which comes in capsule form. Pharmacists should provide the accompanying medication guide to each patient who receives this prescription. The NDC number for this medication is 63304-627-0. It is only available with a prescription.*

FDA Label Image

300 mg Bottle Label (Contain300)

This is a prescription drug called Gabapentin capsules, which come in a bottle of 100 capsules. The pharmacist is advised to dispense a Medication Guide to each patient who receives this drug.*

FDA Label Image

Contain400 (Contain400)

This is a medication called Gabapentin, in the form of capsules. It is only available with a prescription, and it comes with a medication guide that should be given to each patient by the pharmacist. The quantity mentioned is 100 capsules.*

FDA Label Image

Figure 1 (Figure1)

The text provides information about mean pain score, with a value of 10. There are references to "Voo Dos Trsion Paied," "Oplacebs," and "Gabapantin, 3800 moiday," which suggest that the data may come from a study or clinical trial evaluating pain relief treatments. There is also a table or graph with columns labeled "Bidbe," "4," "3," "A," "s," and "1," but it is unclear what this information represents. Overall, without further context it is difficult to provide a more detailed description.*

FDA Label Image

Figure 2 (Figure2)

This appears to be a chart or graph displaying the dosing regimen for two different periods of gabapentin treatment, one 3-week dose titration period and one 8-week fixed dose period. The chart displays the dosage amount in milligrams per day, increasing from 1800 mg/day to 2400 mg/day during the titration period. The chart is labeled with a scale counting weeks.*

FDA Label Image

Figure 3 (Figure3)

The text seems to be a chart displaying the percentage of responders at an endpoint for Study 1 and Study 2. The chart appears to show that Study 1 had a higher percentage of responders at the endpoint compared to Study 2. The text does not provide any details about what the study is about or what the endpoint is.*

FDA Label Image

Figure 4 (Figure4)

FDA Label Image

Mstructure (Mstructure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.